Recent events
Recent events tied to this brand in public sources.
Back to profile10 entries
2026
Bharat Biotech announces lower Mosqivac price
Bharat Biotech announced that the price of its Mosqivac malaria vaccine would be reduced by about 40%, from €9.30 to €5.50 per dose, under an agreement executed by UNICEF and financially backed by Gavi. The lower price is expected to take effect by early 2027.
2026
Bharat Biotech announces lower malaria vaccine price
Bharat Biotech announced an agreement with UNICEF, financially backed by Gavi, to reduce the price of the Mosqivac malaria vaccine by approximately 40 per cent, to EUR 5.50 per dose. The lower price is expected to take effect by early 2027.
2026
Bharat Biotech agrees to reduce Mosqivac price
Bharat Biotech said it reached an equitable pricing agreement with Gavi and UNICEF to reduce the price of its Mosqivac malaria vaccine by about 40%, to €5.50 per dose from early 2027.
2021
Brazil suspends Covaxin contract amid allegations
Brazil’s health ministry announced a temporary suspension of the Covaxin contract amid allegations of possible corruption and irregularities in the vaccine deal. Bharat Biotech denied wrongdoing related to vaccine supply.
2021
Bharat Biotech reduces Covaxin price for states
Bharat Biotech reduced the price of Covaxin for state governments from Rs 600 to Rs 400 per dose.
2021
Bharat Biotech announces Covaxin prices for state and private hospitals
Bharat Biotech announced that Covaxin would be available to state hospitals for Rs 600 per dose and private hospitals for Rs 1,200 per dose.
2020
Bharat Biotech signs COVID-19 vaccine licensing agreement
Bharat Biotech signed a licensing agreement with Washington University School of Medicine for a single-dose intranasal COVID-19 vaccine. Bharat Biotech holds distribution rights in all markets except the US, Japan and Europe.
2020
Dr. Dangs Lab selected for Covaxin clinical trials
Dr. Dangs Lab was selected to partner with Bharat Biotech as the central laboratory for human clinical trials of Covaxin and was processing samples for screening and safety testing.
2020
ICMR and Bharat Biotech partner to develop a COVID-19 vaccine
The Indian Council of Medical Research partnered with Bharat Biotech International Limited to develop an indigenous COVID-19 vaccine using a virus strain isolated at ICMR's National Institute of Virology. Vaccine development work had begun, and ICMR-NIV was to provide ongoing support.
2019
Bharat Biotech launches Rotavac 5D vaccine
Bharat Biotech launched Rotavac 5D, an advanced version of its rotavirus vaccine, to tackle viral diarrhoea.